Rimexolone
From Wikipedia, the free encyclopedia
Rimexolone
|
|
Systematic (IUPAC) name | |
(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | |
Identifiers | |
CAS number | |
ATC code | H02 S01BA13 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C24H34O3 |
Mol. mass | 370.525 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | occular |
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye. It is marketed as a 1% eye drop solution under the trade name Vexol by Alcon Laboratories.
|